Autoantibodies to Igf-1 Binding Sites in Thyroid Associated Ophthalmopathy

References

• Gamblin G., Harper D., Galentine P., Buck D., Chernow B., Eil C. Prevalence of increased intraocular pressure in Graves' disease –evidence of frequent subclinical ophthalmopathy. N. Engl. J. Med. 1983; 308: 420–424
   PubMed Web of Science ®Google Scholar
• McKenzie J M. &McCullagh, E.P. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1968; 28: 1177–1182
   Google Scholar
• Teng C S., Smith B R., Clayton B., Evered D C., Clark F, Hall R. Thyroid-stimulating immunoglobulins in opthalmic Graves' disease. Clinical Endocrinology 1977; 6: 207–211
   PubMedGoogle Scholar
• Feldt-Rasmussen U., Kemp A., Bech K. Serum thyro-globulin:its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos. Acta Endocrinologica 1981; 96: 192–198
   PubMedGoogle Scholar
• Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmic immunoglobulin in patients with Graves' opthalm-opathy. Lancet 1984; ii: 374–376
   Google Scholar
• Kroll A J., Kuwabara T. Dysthyroid ocular myopathy. Archives of Ophthalmology 1966; 76: 244–256
   PubMedGoogle Scholar
• Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retroorbital and thyroid autoimmunity. British Medical Journal 1984; 228: 1183–1189
   Google Scholar
• Bahn R S., Gorman C A., Woloschak G E., David C S., Johson P M., Johson CM. Human retroocular fibroblast in vitro. A model for study of Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 1987; 65: 665–670
   PubMed Web of Science ®Google Scholar
• Perros P., Kendall-Taylor P. Antibodies to orbital tissues in thyroid associated ophthalmopathy. Acta Endocrinologica 1992; 126: 137–142
   Google Scholar
• Rotella CM., Zonefrati R., Toccafondi R., Valente W A., Kohn L D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts. An assay which appears to measure exophthal-mogenic immunoglobulins in Graves' sera. Journal of Clinical Endocrinology and Metabolism 1986; 62: 357–367
   PubMed Web of Science ®Google Scholar
• Perros P., Kendall-Taylor P. Biological activity of autoantibodies from patients with thyroid associated ophthalmopathy. Invitro effects on porcine extraocular myoblasts. Quarterly Journal of Medicine 1992; 84: 691–706
   Google Scholar
• Atkinson S., Hardwick M., Kendall-Taylor P. Thyrotrophin-blocking antibodies in goitrous primary hypothyroidism:detection by a highly sensitive bioassay and determination of site of action. Journal of Endocrinology 1988; 118: 141–147
   PubMedGoogle Scholar
• Weightman D R., Shale D J., Tomlinson W R. A rapid radioassay for human IgG produced in lymphocyte in vitro culture systems. Journal of Immunological Methods 1981; 46: 307–312
   PubMedGoogle Scholar
• Fraker P J., Speck J C. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochemistry Biophysics Research Communications 1978; 80: 849–857
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Annals New York Academy of Science 1949; 51: 660–672
   Web of Science ®Google Scholar
• Wang J F., Beeks G P., Buckingham K D., Hill D J. Characterisation of insulin-like growth factor binding proteins secreted by isolated sheep thyroid epithelial cells. Journal of Endocrinology 1990; 125: 439–448
   PubMed Web of Science ®Google Scholar
• Salvi M, Miller A., Wall J. R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognised by autoantibodies in the serum of patients with thyroid associated ophthalmopathy. FEBS Letters 1988; 232: 135–139
   PubMed Web of Science ®Google Scholar
• Weightman D R., Kendall-Taylor P. Cross-reaction of eye muscle antibodies with thyroid tissue in thyroid associated ophthalmopathy. Journal of Endocrinology 1989; 122: 201–206
   PubMed Web of Science ®Google Scholar
• Mahieu P., Winand R. J. Demonstration of hypersensitivity to retrorbular and thyroid tissues in human exophthalmos. Journal of Clinical Endocrinology and Metabolism 1972; 34: 1090
   PubMed Web of Science ®Google Scholar
• Munro D E., Lamki L., Row V V., Volpe R. Cell mediated immunity in the exophthalmos of Graves' disease as demonstrated by the MIF test. Journal of Endocrinology and Metabolism 1973; 37: 286–292
   PubMed Web of Science ®Google Scholar
• Singer J. Neonatal thyrotoxicosis. Journal of Pediatrics 1977; 91: 749–751
   PubMed Web of Science ®Google Scholar
• Glinoer D., Etienne-Decerf J., Schrooyen M., Sand G., Hoyoux P., Mathieu P., Winand R. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrino-logica 1986; 111: 30–38
   PubMedGoogle Scholar
• Hufnagel T J., Hickey W F., Cobbs N H., Jacobiec F A., Iwamato T., Eagle R. C. Immunohistochemical ultra-structural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984; 91: 1411–1419
   PubMed Web of Science ®Google Scholar
• Ludwig A W., Boas N F., Soffer L J. Role of mucopolysaccharides in the pathogenesis of experimental exophalmos. Proceedings of the Society of Experimental Biology and Medicine. 1950; 73. 1950, 137–140
   Google Scholar
• Falconer M A., Alexander W S. Experiences with malignant exophalmos. British Journal of Ophthalmology 1951; 35: 253
   Google Scholar
• Riley F C. Orbital pathology in Graves' disease. Mayo Clinic Proceedings. 1972, 975–979, 47
   Google Scholar
• Hansson H A., Petruson B., Skottner A. Somatomedin C in the pathogenesis of malignant exophthalmos of endocrine origin. Lancet 1986; 2: 218–219
   Google Scholar
• Rosenfeld R G., Dollar L A. Characterisation of the somatomedin C/insulin like growth factor 1 (SM-C/IGF-1) receptor on cultured human fibroblast monolayers. Regulation of receptor concentrations by SM-C/IGF-1 and insulin. Journal of Clinical Endocrinology and Metabolism 1982; 55: 434–439
   Google Scholar
• Jonas H A., Harrison L C. The human placenta contains two distinct binding and immunoreactive species of insulin like growth factor-1 receptors. Journal of Biological Chemistry 1985; 4: 2288–2294
   Google Scholar
• Tollefsen S E., Thompson K., Petersen D. J. Separation of the high affinity insulin like growth factor 1 receptor from low affinity binding sites by affinity chromatography. Journal of Biological Chemistry 1987; 5: 16461–16469
   Google Scholar